期刊文献+

替格瑞洛临床应用中国专家共识 被引量:38

下载PDF
导出
摘要 冠心病是一种猝死率高、危害严重的常见疾病,规范冠心病管理是改善预后、降低死亡率的关键,无论采取药物或介入治疗,抗血小板治疗均是冠心病管理的基石。双联抗血小板,即阿司匹林联合一种P2Y12受体拮抗剂是急性冠状动脉综合征(acute coronary syndromes,ACS)和(或)经皮冠状动脉介入(percutaneous coronary intervention,PCI)患者的标准治疗。
作者 韩雅玲
出处 《临床军医杂志》 CAS 2016年第5期444-453,共10页 Clinical Journal of Medical Officers
  • 相关文献

参考文献65

  • 1Wallentin L,Becker RC,Budaj A,et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2009,361(11):1045-1057.DOI:10.1056/NEJMoa0904327.
  • 2Hamm CW,Bassand JP,Agewall S,et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:The Task Force for the management of acute coronary syndromes(ACS)in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2011,32(23):2999-3054.DOI:10.1093/eurheartj/ehr236.
  • 3O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].J Am Coll Cardiol,2013,61(4):e78-e140.DOI:10.1016/j.jacc.2012.11.019.
  • 4Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2014,35(37):2541-2619.DOI:10.1093/eurheartj/ehu278.
  • 5Amsterdam EA,Wenger NK,Brindis RG,et al.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J].Circulation,2014,130(25):e344-e426.DOI:10.1161/CIR.0000000000000134.
  • 6无,沈卫峰,胡大一.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. 被引量:676
  • 7中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012,40(4):271-277. 被引量:424
  • 8无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393. 被引量:2261
  • 9Wallentin L,James S,Storey RF,et al.Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes:a genetic substudy of the PLATO trial[J].Lancet,2010,376(9749):1320-1328.DOI:10.1016/S0140-6736(10)61274-3.
  • 10Li H,Butler K,Yang L,et al.Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects:an open-label,sequential,two-cohort,single-centre study[J].Clin Drug Investig,2012,32(2):87-97.DOI:10.2165/11595930-000000000-00000.

二级参考文献122

共引文献3652

同被引文献355

引证文献38

二级引证文献578

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部